Cite
MLA Citation
E. Keystone et al.. “THU0228 Tofacitinib, an Oral Janus Kinase Inhibitor: Post-HOC Analyses of Efficacy and Safety of Monotherapy Versus Combination Therapy in a Phase 3 Rheumatoid Arthritis Population.” Annals of the rheumatic diseases, vol. 72, 2013, p. A242. http://access.bl.uk/ark:/81055/vdc_100136719007.0x000063